 risk leukemia relaps high-dos cyclosporin allogen marrow transplant acut leukemia patient acut myeloid leukemia anll acut lymphoblast leukemia all year mg/kg day group mg/kg day group cyclosporin cya day day bone marrow transplant bmt patient cya patient cyclophosphamid CY mg/kg total bodi irradi tbi unfraction BM hla-ident sibl group compar diagnosi diseas statu french-american-british fab classif wbc count diagnosi cytogenet abnorm extramedullari diseas bmt donor/recipi age sex number cell number day intraven IV cya median follow-up patient group day group patient group serum level cya ng/ml bilirubin level mg/dl creatinin level mg/dl proport cell peripher blood PB day first day /L neutrophil compar group day cox model actuari risk acut graft-v-host diseas gvhd ii+ stratif age year group patient actuari risk chronic gvhd compar actuari transplant-rel mortal trm day group major caus death gvhd group multiorgan toxic group actuari risk relaps year overal group group patient first remiss patient non-first complet remiss CR actuari disease-fre surviv df group patient first remiss advanc diseas abstract truncat AT word